Clinical Trials Browser

OTHER × Carcinoma, Neuroendocrine × cabozantinib × Clear all

NCT04524208 2024-08-13

CABONEN

Phase 2 Active not recruiting

Carcinoma, Neuroendocrine, Neuroendocrine Tumors